go back

Tennessee rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $602,560 · 10th–90th $489,779–$977,2370%20%40%10th90th$602,560Professionalmedian $489,779 · 10th–90th $489,779–$537,0320%50%90th$489,779$100.0K$200.0K$500.0K$1.0M$2.0M$5.0M$10.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $851,138.04
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $537,031.80
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $549,540.87
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $537,031.80 / $588,843.66
Lucent Health
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$977,237.22 / $977,237.22 / $977,237.22
Lucent Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$1,000,000.00 / $1,000,000.00 / $1,000,000.00
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $512,861.38 / $1,047,128.55
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $489,778.82 / $524,807.46